Preliminary Study on Changes of Sleep EEG Power and Plasma Melatonin in Male Patients With Major Depressive Disorder After 8 Weeks Treatment

Objective: To clarify the effects of escitalopram on sleep EEG power in patients with Major depressive disorder (MDD).Method: Polysomnography (PSG) was detected overnight, and blood samples were collected at 4 h intervals over 24 h from 13 male healthy controls and 13 male MDD patients before and af...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xue-Qin Wang, De-Quan Wang, Yan-Ping Bao, Jia-Jia Liu, Jie Chen, Shao-Wei Wu, Hsuan-Nu Luk, Ling Yu, Wei Sun, Yong Yang, Xue-Hua Wang, Lin Lu, Jia-Hui Deng, Su-Xia Li
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/f199aa0a50894012a2412486a3a6d6fb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f199aa0a50894012a2412486a3a6d6fb
record_format dspace
spelling oai:doaj.org-article:f199aa0a50894012a2412486a3a6d6fb2021-11-12T05:21:22ZPreliminary Study on Changes of Sleep EEG Power and Plasma Melatonin in Male Patients With Major Depressive Disorder After 8 Weeks Treatment1664-064010.3389/fpsyt.2021.736318https://doaj.org/article/f199aa0a50894012a2412486a3a6d6fb2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fpsyt.2021.736318/fullhttps://doaj.org/toc/1664-0640Objective: To clarify the effects of escitalopram on sleep EEG power in patients with Major depressive disorder (MDD).Method: Polysomnography (PSG) was detected overnight, and blood samples were collected at 4 h intervals over 24 h from 13 male healthy controls and 13 male MDD patients before and after treatment with escitalopram for 8 weeks. The outcome measures included plasma melatonin levels, sleep architecture, and the sleep EEG power ratio.Results: Compared with healthy controls, MDD patients presented abnormalities in the diurnal rhythm of melatonin secretion, including peak phase delayed 3 h and a decrease in plasma melatonin levels at night and an increase at daytime, accompanied by sleep disturbances, a decrease in low-frequency bands and an increase in high-frequency bands, and the dominant right-side brain activity. Several of these abnormalities (abnormalities in the diurnal rhythm of melatonin secretion, partial sleep architecture parameters) persisted for at least the 8-week testing period.Conclusions: Eight weeks of treatment with escitalopram significantly improved subjective sleep perception and depressive symptoms of patients with MDD, and partially improved objective sleep parameters, while the improvement of circadian rhythm of melatonin was limited.Xue-Qin WangDe-Quan WangYan-Ping BaoJia-Jia LiuJie ChenShao-Wei WuShao-Wei WuHsuan-Nu LukLing YuWei SunYong YangXue-Hua WangLin LuLin LuLin LuJia-Hui DengSu-Xia LiSu-Xia LiFrontiers Media S.A.articlemajor depressive disorderpolysomnographyescitaloprammelatoninsleep EEG powerPsychiatryRC435-571ENFrontiers in Psychiatry, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic major depressive disorder
polysomnography
escitalopram
melatonin
sleep EEG power
Psychiatry
RC435-571
spellingShingle major depressive disorder
polysomnography
escitalopram
melatonin
sleep EEG power
Psychiatry
RC435-571
Xue-Qin Wang
De-Quan Wang
Yan-Ping Bao
Jia-Jia Liu
Jie Chen
Shao-Wei Wu
Shao-Wei Wu
Hsuan-Nu Luk
Ling Yu
Wei Sun
Yong Yang
Xue-Hua Wang
Lin Lu
Lin Lu
Lin Lu
Jia-Hui Deng
Su-Xia Li
Su-Xia Li
Preliminary Study on Changes of Sleep EEG Power and Plasma Melatonin in Male Patients With Major Depressive Disorder After 8 Weeks Treatment
description Objective: To clarify the effects of escitalopram on sleep EEG power in patients with Major depressive disorder (MDD).Method: Polysomnography (PSG) was detected overnight, and blood samples were collected at 4 h intervals over 24 h from 13 male healthy controls and 13 male MDD patients before and after treatment with escitalopram for 8 weeks. The outcome measures included plasma melatonin levels, sleep architecture, and the sleep EEG power ratio.Results: Compared with healthy controls, MDD patients presented abnormalities in the diurnal rhythm of melatonin secretion, including peak phase delayed 3 h and a decrease in plasma melatonin levels at night and an increase at daytime, accompanied by sleep disturbances, a decrease in low-frequency bands and an increase in high-frequency bands, and the dominant right-side brain activity. Several of these abnormalities (abnormalities in the diurnal rhythm of melatonin secretion, partial sleep architecture parameters) persisted for at least the 8-week testing period.Conclusions: Eight weeks of treatment with escitalopram significantly improved subjective sleep perception and depressive symptoms of patients with MDD, and partially improved objective sleep parameters, while the improvement of circadian rhythm of melatonin was limited.
format article
author Xue-Qin Wang
De-Quan Wang
Yan-Ping Bao
Jia-Jia Liu
Jie Chen
Shao-Wei Wu
Shao-Wei Wu
Hsuan-Nu Luk
Ling Yu
Wei Sun
Yong Yang
Xue-Hua Wang
Lin Lu
Lin Lu
Lin Lu
Jia-Hui Deng
Su-Xia Li
Su-Xia Li
author_facet Xue-Qin Wang
De-Quan Wang
Yan-Ping Bao
Jia-Jia Liu
Jie Chen
Shao-Wei Wu
Shao-Wei Wu
Hsuan-Nu Luk
Ling Yu
Wei Sun
Yong Yang
Xue-Hua Wang
Lin Lu
Lin Lu
Lin Lu
Jia-Hui Deng
Su-Xia Li
Su-Xia Li
author_sort Xue-Qin Wang
title Preliminary Study on Changes of Sleep EEG Power and Plasma Melatonin in Male Patients With Major Depressive Disorder After 8 Weeks Treatment
title_short Preliminary Study on Changes of Sleep EEG Power and Plasma Melatonin in Male Patients With Major Depressive Disorder After 8 Weeks Treatment
title_full Preliminary Study on Changes of Sleep EEG Power and Plasma Melatonin in Male Patients With Major Depressive Disorder After 8 Weeks Treatment
title_fullStr Preliminary Study on Changes of Sleep EEG Power and Plasma Melatonin in Male Patients With Major Depressive Disorder After 8 Weeks Treatment
title_full_unstemmed Preliminary Study on Changes of Sleep EEG Power and Plasma Melatonin in Male Patients With Major Depressive Disorder After 8 Weeks Treatment
title_sort preliminary study on changes of sleep eeg power and plasma melatonin in male patients with major depressive disorder after 8 weeks treatment
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/f199aa0a50894012a2412486a3a6d6fb
work_keys_str_mv AT xueqinwang preliminarystudyonchangesofsleepeegpowerandplasmamelatonininmalepatientswithmajordepressivedisorderafter8weekstreatment
AT dequanwang preliminarystudyonchangesofsleepeegpowerandplasmamelatonininmalepatientswithmajordepressivedisorderafter8weekstreatment
AT yanpingbao preliminarystudyonchangesofsleepeegpowerandplasmamelatonininmalepatientswithmajordepressivedisorderafter8weekstreatment
AT jiajialiu preliminarystudyonchangesofsleepeegpowerandplasmamelatonininmalepatientswithmajordepressivedisorderafter8weekstreatment
AT jiechen preliminarystudyonchangesofsleepeegpowerandplasmamelatonininmalepatientswithmajordepressivedisorderafter8weekstreatment
AT shaoweiwu preliminarystudyonchangesofsleepeegpowerandplasmamelatonininmalepatientswithmajordepressivedisorderafter8weekstreatment
AT shaoweiwu preliminarystudyonchangesofsleepeegpowerandplasmamelatonininmalepatientswithmajordepressivedisorderafter8weekstreatment
AT hsuannuluk preliminarystudyonchangesofsleepeegpowerandplasmamelatonininmalepatientswithmajordepressivedisorderafter8weekstreatment
AT lingyu preliminarystudyonchangesofsleepeegpowerandplasmamelatonininmalepatientswithmajordepressivedisorderafter8weekstreatment
AT weisun preliminarystudyonchangesofsleepeegpowerandplasmamelatonininmalepatientswithmajordepressivedisorderafter8weekstreatment
AT yongyang preliminarystudyonchangesofsleepeegpowerandplasmamelatonininmalepatientswithmajordepressivedisorderafter8weekstreatment
AT xuehuawang preliminarystudyonchangesofsleepeegpowerandplasmamelatonininmalepatientswithmajordepressivedisorderafter8weekstreatment
AT linlu preliminarystudyonchangesofsleepeegpowerandplasmamelatonininmalepatientswithmajordepressivedisorderafter8weekstreatment
AT linlu preliminarystudyonchangesofsleepeegpowerandplasmamelatonininmalepatientswithmajordepressivedisorderafter8weekstreatment
AT linlu preliminarystudyonchangesofsleepeegpowerandplasmamelatonininmalepatientswithmajordepressivedisorderafter8weekstreatment
AT jiahuideng preliminarystudyonchangesofsleepeegpowerandplasmamelatonininmalepatientswithmajordepressivedisorderafter8weekstreatment
AT suxiali preliminarystudyonchangesofsleepeegpowerandplasmamelatonininmalepatientswithmajordepressivedisorderafter8weekstreatment
AT suxiali preliminarystudyonchangesofsleepeegpowerandplasmamelatonininmalepatientswithmajordepressivedisorderafter8weekstreatment
_version_ 1718431203786227712